Drug profile · INN
vancomycin hydrochloride
VANCOMYCIN HYDROCHLORIDE
vancomycin hydrochloride (VANCOMYCIN HYDROCHLORIDE) is a peptidoglycan inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous, oral. Current US regulatory status: approved.
Drug details — vancomycin hydrochloride
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS, ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
vancomycin hydrochloride (VANCOMYCIN HYDROCHLORIDE) is a peptidoglycan inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous, oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Peptidoglycan inhibitor
Primary target: Peptidoglycan
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is vancomycin hydrochloride?
vancomycin hydrochloride (VANCOMYCIN HYDROCHLORIDE) is a peptidoglycan inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous, oral. Current US regulatory status: approved.
What is the brand name for vancomycin hydrochloride?
VANCOMYCIN HYDROCHLORIDE is a marketed brand name for vancomycin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of vancomycin hydrochloride?
vancomycin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.